Cystic fibrosis in Uruguay
G. Luzardo,I. Aznarez,B. Crispino,A. Mimbacas,L. Martínez,R. Poggio,J. Zielenski,L. C. Tsui and H. Cardoso. Cystic fibrosis in Uruguay. Genet Mol Res. 2002;1(1).
Cystic fibrosis in Uruguay Ver más »
Publicaciones Científicas
Current calcium fortification experiences: a review
C. Palacios,G. J. Hofmeyr,G. Cormick,M. N. Garcia-Casal,J. P. Pena-Rosas and A. P. Betran. Current calcium fortification experiences: a review. Annals of the New York Academy of Sciences. 2021;1484(1):10.1111/nyas.14481.
Current calcium fortification experiences: a review Ver más »
Critical care providers’ opinion on unsafe abortion in Argentina
D. N. Vasquez,A. V. Das Neves,J. L. Golubicki,I. Di Marco,C. I. Loudet,J. E. Roberti,J. Palacios-Jaraquemada,N. Basualdo,R. Varaglia and L. Vidal. Critical care providers' opinion on unsafe abortion in Argentina. Int J Gynaecol Obstet. 2012;116(3):10.1016/j.ijgo.2011.10.030.
Critical care providers’ opinion on unsafe abortion in Argentina Ver más »
COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL
A. Pichon-Riviere,J. Caporale,C. von Schulz-Hausmann and F. A. Augustovski. COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL. Value in Health. 2009;12(7):10.1016/s1098-3015(10)75391-2.
Cost-Effectivity of Implantable Cardioverter Defibrillators in Patients with Risk Factors for Sudden Death in Argentina
A. Alcaraz,J. Gonzalez-Zuelgaray and F. Augustovski. Cost-Effectivity of Implantable Cardioverter Defibrillators in Patients with Risk Factors for Sudden Death in Argentina. Value in Health. 2011;14(5):10.1016/j.jval.2011.05.030.
Cost-effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review
J. P. Vogel,A. N. Wilson,N. Scott,M. Widmer,F. Althabe and O. T. Oladapo. Cost-effectiveness of uterine tamponade devices for the treatment of postpartum hemorrhage: A systematic review. Int J Gynaecol Obstet. 2020;151(3):10.1002/ijgo.13393.
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela
S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,C. A. Obando and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA. Value in Health. 2013;16(7).
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile
S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,D. O. Reisberg,A. S. Ried,J. Poniachik,J. R. B. Barril and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN CHILE. Value in Health. 2013;16(7).
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia
S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,V. Idrovo,J. P. Ortiz,M. Tapias,J. Obregon,J. G. Ariza and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA. Value in Health. 2013;16(7).
Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina
S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,F. Bessone,H. Fainboim,A. Gadano,O. Galdame,C. Vujacich and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ARGENTINA. Value in Health. 2013;16(7).